title: [Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF)].
authors.affiliation: CHRU de Lille, institut de pharmacie, rue Philippe-Marache, 59037 Lille, France; Université de Lille, 59000 Lille, France; Faculté de pharmacie, UDSL, EA7365 GRITA, 3, rue du Professeur-Laguesse, 59000 Lille, France. Electronic address: nicolas.simon@univ-lille2.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Simon
authors.affiliation: CHRU de Lille, institut de pharmacie, rue Philippe-Marache, 59037 Lille, France; Faculté de pharmacie, UDSL, EA7365 GRITA, 3, rue du Professeur-Laguesse, 59000 Lille, France.
authors.forename: Michèle
authors.initials: M
authors.lastname: Vasseur
authors.affiliation: CHRU d'Amiens, service d'oncologie médicale, 80054 Amiens, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Chauffert
authors.affiliation: CHRU de Nancy, service de neurologie, 54035 Nancy, France.
authors.forename: Luc
authors.initials: L
authors.lastname: Taillandier
authors.affiliation: Université Lille 1, laboratoire Prism, Inserm U1192, 59655 Villeneuve-d'Ascq, France; CHRU de Lille, hôpital Roger-Salengro, service de neurochirurgie, neuro-oncologie, rue Emile-Laine, 59037 Lille, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Le Rhun
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002173:Cancer Care Facilities / Q000592:standards; D005602:France; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D017410:Practice Guidelines as Topic; D012955:Societies, Medical
chemical_list: D000970:Antineoplastic Agents